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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
To evaluate the outcomes of inguinal and femoral hernia repair techniques in adults, specifically comparing closure with mesh versus
without mesh.
B A C K G R O U N D
Description of the condition
A hernia is defined as a protrusion of an organ or part of an
organ through the body wall that normally contains it (Brooks
2014a). Abdominal wall hernias are common, with a prevalence
in the general population of 4% for those aged over 45 years (
Jenkins 2008). Inguinal and femoral hernias are knowncollectively
as groin hernias (Brooks 2014a). Of all groin hernias, 96% are
inguinal and 4% are femoral (Rutkow 1993). Men are eight times
more likely to develop a groin hernia than women and 20 times
more likely to require a groin hernia repair (Brooks 2014a).
Groin hernias may present as a heaviness or discomfort in the
groin region, or a visible or palpable bulge. Discomfort is usually
most pronounced when intra-abdominal pressure is increased, for
example with heavy lifting, straining or prolonged standing. Risk
factors for groin hernias include history of hernia or prior hernia
repair, older age, male sex, chronic cough, chronic constipation,
abdominal wall injury, smoking and family history of hernia (
Brooks 2014a). The current literature seems to support the view
that obesity may be a protective factor for groin hernias (Liem
1997; Rosemar 2008; Ruhl 2007).
Inguinal hernias are the most common type of hernia in both gen-
ders, accounting for 75% of all abdominal wall hernias, with a
lifetime risk of 27% in men and 3% in women (Jenkins 2008).
Inguinal hernias are classified as congenital or acquired (Brooks
2014a). Congenital inguinal hernias are caused by a failure of the
processus vaginalis (invagination of the parietal peritoneum that
precedes the migration and descent of the testes in males) to close.
The portion of the processus vaginalis within the inguinal canal is
called the ’canal of Nuck’ in females and usually obliterates by the
eighth foetal month of life (Brooks 2014a). In contrast, acquired
hernias are due to the weakening or disruption of the fibromuscu-
lar tissues of the abdominal wall, allowing the protrusion of intra-
abdominal contents through the acquired defect (Brooks 2014a).
This may be facilitated by inherent connective tissue abnormal-
ities, chronic abdominal wall injury (including any chronic in-
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creased intra-abdominal pressure) and possibly adverse effects of
drugs such as glucocorticoids (thinning of skin and weakening of
soft tissues) or smoking (Brooks 2014a; Cannon 1981; Sorenson
2002). Acquired hernias canpresent acutely andmay require emer-
gency surgical intervention.
Inguinal hernias are further classified as indirect or direct. Indi-
rect inguinal hernias protrude through the internal inguinal ring,
which is the site where the spermatic cord in males and the round
ligament in females exits the abdomen (Brooks 2014a). Direct
inguinal hernias protrude medial to the inferior epigastric vessels
within Hesselbach’s triangle (formed by the inguinal ligament in-
feriorly, the inferior epigastric vessels laterally and the rectus ab-
dominis muscle medially) (Brooks 2014a). Femoral hernias are
located inferior to the inguinal ligament and protrude through the
femoral ring, medial to the femoral sheath containing the femoral
artery and vein. Femoral hernias are acquired; the femoral ring can
widen with age or injury (Brooks 2014a). Femoral hernias repre-
sent 20% to 31% of repairs in women compared to only 1% in
men (Brooks 2014a).
It is important to differentiate femoral hernias from inguinal her-
nias given that femoral hernias are more likely to strangulate.
As women are more likely to have femoral hernias than men, a
relatively high proportion of women who present acutely with
a symptomatic acquired hernia will require emergency manage-
ment compared to their male counterparts. (Dahlstrand 2009;
Koch 2005; Rosemar 2010). Classically, femoral hernias present
as mildly painful non-reducible groin lumps located inferolateral
to the pubic tubercle; inguinal hernias are generally found super-
olaterally to the pubic tubercle (Whalen 2011). However, femoral
hernias tend to move above the inguinal ligament, where they
may be mistaken for an inguinal hernia. Differentiation on clinical
grounds is notoriously unreliable, and unrelated to the experience
of the examining practitioner (Whalen 2011). Ultrasonography,
computed tomography or even diagnostic laparoscopy may have a
role in further investigation of hernia type or occult hernia (Brooks
2014a; Whalen 2011).
Groin herniasmay present as emergencies with complications such
as bowel incarceration and obstruction or strangulation (Brooks
2014a). Incarceration refers to the irreducible trapping of hernia
contents within the hernia sac. Reduced venous and lymphatic
flow leads to swelling of the incarcerated tissue, which can lead to
impediment of arterial supply resulting in ischaemia and necrosis
of the hernia contents (strangulation). The overall risk of incar-
ceration and strangulation is low, between 0.3% and 3% per year
(Brooks 2014a; Fitzgibbons 2006; Gallegos 1991).
Description of the intervention
The definitive treatment of all hernias is surgical repair, re-
gardless of hernia origin or type. Repair of inguinal hernias is
one of the most common general surgical procedures performed
(McCormack 2003; Rutkow 1993). Urgent emergency surgical
repair is indicated for patients who develop complications. If this
is undertaken within approximately four to six hours fromonset of
symptoms, an emergency surgical repair may prevent loss of bowel
from prolonged strangulation (Brooks 2014b). However, for un-
complicated hernias, the optimal timing of repair and aspects of re-
pair technique remain controversial. Currently it is recommended
that patients with symptomatic hernias should undergo an elective
hernia repair. For patients who are asymptomatic but have risk fac-
tors for groin hernia incarceration or strangulation, a hernia repair
is generally undertaken as soon as is feasible (Brooks 2014b). For
male patients with minimal symptoms, with a ’watchful waiting’
approach to treatment, the cumulative probability of developing
problems such as increasing pain, incarceration or strangulation
is 2.8% at three months, 4.5% to 23% at two years and 31% at
four years (Fitzgibbons 2006; Gallegos 1991; O’Dwyer 2006).
The aimof hernia repair surgery is not only to fix the current hernia
defect, but also to reduce the risk of recurrence. Recurrence rates
for primary hernia repair range from 0.5% to 15% depending on
the hernia site, type of repair and clinical circumstances (Brooks
2014b).
Groin hernia repairs can involve the use of a mesh (otherwise
known as a hernioplasty) or no mesh (that is, herniorrhaphy). The
mesh used in hernia repair is typically made from a synthetic poly-
mer, usually polypropylene, which is inert and does not cause ab-
normal inflammation. The mesh is lightweight and flexible, and
designed to avoid impediment of local structures or positional
movement. Meshes may be held in place using partially dissolv-
able sutures and/or a fibrin glue, of which the glue may produce a
more effective seal (Brooks 2014b). A mesh repair involves cover-
ing the hernial defect by placing the mesh on one of the layers of
the abdominal wall either using an open approach or a minimal
access laparoscopic technique (McCormack 2003). The approach
to repair depends on a number of factors in each individual case,
including the type of hernial defect, patient factors and the sur-
geon’s preference. With the open approach, the repair is gener-
ally anterior to the hernial defect, whereas laparoscopic repair is
approached from a posterior aspect. Prosthetic mesh is being in-
creasingly incorporated into hernia surgery (either open or laparo-
scopic) as a component of tension-free repair (Brooks 2014b).
Open techniques for inguinal hernia repairs include tension-free
mesh repairs such as the Lichtenstein, plug and patch, and Kugel
(preperitoneal) repairs, and non-mesh primary tissue approxima-
tion repairs such as the Shouldice, Bassini and McVay repairs
(Brooks 2014b). In the tension-free mesh repair category, the
mesh is placed in front of the transversalis fascia, such as with the
Lichtenstein tension-free hernioplasty, or behind the transversalis
fascia in the preperitoneal space, for example, the Kugel proce-
dure (Amid 2005). With the tissue approximation repairs, which
do not involve mesh placement, the Shouldice technique is gen-
erally the preferred suture-based repair, which involves a four-
layer reconstruction of the fascia transversalis. Alternatives to the
Shouldice technique include the original Bassini method in which
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the edges of the defect are simply sewn back together with tension
and, less commonly, the McVay method. The McVay method in-
volves reinforcement of the inguinal canal by approximating the
transversus abdominis aponeurosis and transversalis fascia to the
pectineal ligament, thus restoring the canal floor by bringing to-
gether the femoral sheath and the inguinal ligament. It is impor-
tant to note that the McVay style of repair is also typically used
in open femoral hernia repairs, with possible approaches from an
infra-inguinal (Lockwood), trans-inguinal (Lotheissen) or supra-
inguinal (McEvedy) aspect (Amid 2005).
The two main laparoscopic groin hernia repairs are the totally
extraperitoneal (TEP) and transabdominal preperitoneal patch
(TAPP) repairs (Bittner 2011), both requiring the use of a mesh.
TEP repair is performed by gaining access to the preperitoneal
space (that is, the space between the peritoneum and the anterior
abdominal wall) using an anterior approach, without ever actually
entering the abdomen (Ferzli 1998;McKernan 1993). A TAPP re-
pair, on the other hand, requires the surgeon to enter the peritoneal
(abdominal) cavity to access the preperitoneal space. Some of the
more significant disadvantages of this approach include potential
injury to adjacent organs and, long-term, adhesions resulting in
bowel obstruction (Wake 2005; Vader 1997).
Common early complications of hernia repair surgery include
wound seroma or haematoma, urinary retention, bladder injury
and superficial wound infection. Complications that may occur
later following hernia repair surgery include persistent groin pain
and post-herniorrhaphy neuralgia, testicular complications, deep
wound or mesh infection, recurrent hernia and mesh migration or
erosion (Brooks 2014c). The incidence of post-surgical complica-
tions is more common following emergent repairs and recurrent
hernia repairs (Brooks 2014c).
A Cochrane review published in 2008 showed that whilst laparo-
scopic repairs were associated with quicker recovery times and less
persistent pain, the procedure itself usually takes longer and has
higher rates of bladder and vascular injuries. Hernia recurrence
post laparoscopic mesh repair was less common compared to open
non-mesh repair, with the main indicator of recurrence related to
the use of a mesh rather than the approach itself (McCormack
2003).
How the intervention might work
Prior to 1958, abdominal wall hernias were closed with primary
suture repair. Tension on the weak fascia was thought to be one of
the main contributing factors to repair failure. Then, in 1958, Dr
Francis Usher published his ’tension-free’ technique using a per-
manently implanted polypropylene mesh (Read 1999). This led
to the Lichtenstein repair some 30 years later, which popularised
mesh for hernia repair. The logic that Usher used to explain his
use of polypropylene mesh was this: the mesh was a material that
could be used to close over the hernial defect and provide ongoing
reinforcement to the attenuated fascia of the abdominal wall by
encouraging growth of connective tissue (scar tissue) around and
through the mesh fibres (Doctor 2006). It was expected that the
best meshes would be those made of very strong material and able
to induce the most fibrosis. Unfortunately, this fibrotic reaction
led to pain andmovement restriction and it soon became clear that
this needed to be reduced. In order to do this, the surface area, and
therefore strength, of the mesh had to be reduced. Calculations
of intra-abdominal pressures proved that this would be possible
without compromising mesh function. In fact, the tensile strength
of a mesh required to withstand the maximum abdominal pres-
sure is only a tenth of that of most meshes (Brown 2010). This
realisation led to the concept of light-weight meshes.
Light-weight meshes were first introduced in 1998 (Vypro) and
their superiority over the heavy-weight meshes is now widely ac-
cepted. These meshes have large pores (normally 3 to 5 mm) and
a small surface area. They stimulate a reduced inflammatory reac-
tion and, therefore, have greater elasticity and flexibility (Klinge
2008). They also shrink less and have been shown to cause less
pain compared to heavier meshes after Lichtenstein inguinal her-
nia repairs. Unfortunately, despite these improvements, patients
continue to have complications such as recurrence, infection and
adhesion formation (Brown 2010). Thus, the search for an ideal
mesh continued.
The difficulty of finding a single, ’ideal’ mesh is acknowledged by
the development of composite meshes. These combine more than
onematerial and are the basis of most newmesh designs. Themain
advantage of the composite meshes is that they can be used in
the intraperitoneal space with minimal adhesion formation. De-
spite the vast selection of brands available, nearly all these meshes
continue to use one of the three basic materials: polypropylene,
polyester and expanded polytetraflouroethylene (ePTFE). These
are used in combination with each other or with a range of addi-
tional materials such as titanium, omega 3, Monocryl, polyvinyli-
dene difluoride (PVDF) and hyaluronate. However, as might be
expected, none of these synthetic materials are without disadvan-
tages (O’Dwyer 2005).
The problems encountered with synthetic materials led to the de-
velopment of bio-materials, which are currently the most physi-
ologically based implants. These consist of an acellular collagen
matrix derived from human dermis (Aderm) or porcine small in-
testine submucosa (Surgisis). The matrix allows soft tissue to infil-
trate the mesh which eventually becomes integrated into the body
by a process of remodelling. Unfortunately, this process also ap-
pears to lead to a rapid reduction in their mechanical strength, and
concerns regarding this have restricted their use to infected envi-
ronments (where one would normally use an absorbable synthetic
material such as Vicryl) (Brown 2010).
Why it is important to do this review
Currently, about one million meshes are used per year world-wide
in hernia repairs (Klinge 2002). In 2002, the EU Hernia Trialists
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Collaboration analysed 58 randomised controlled trials and found
that the use of mesh was superior to other techniques; in partic-
ular, the meta-analyses noted fewer recurrences and less postop-
erative pain with mesh repair compared to all other techniques
(EUHernia Trialists 2002). Despite the favourable results of mesh
repair and its adoption as common practice in developed coun-
tries, it has yet to be integrated as standard practice by all surgeons
(Nixon 2009). Non-mesh repairs are still commonly performed
worldwide, particularly in developing countries; for example, in
African countries, when surgical treatment is provided (65% to
75% as an emergency procedure rather than elective), fewer than
5% of hernias are repaired using implanted mesh (Yang 2011).
This is likely to be related to the increased costs involved in mesh
(and also laparoscopic) repair which can be unaffordable in coun-
tries where the typical per capita government health expenditure
(USD 28 in Ghana, USD 7 in Uganda) is usually less than the
price of a single-use package of commercial mesh (USD40 to 100)
(Yang 2011). The biological meshes are available at an even higher
cost (Klinge 2008). Research into low-cost mesh alternatives (such
as mosquito-net mesh) and innovative construction of standard
commercial meshes are being undertaken and show promise (Yang
2011).
An updated meta-analysis of the current literature is needed re-
garding the use of mesh in inguinal and femoral hernia repairs.
In clinical practice, laparoscopy is increasingly used as the opera-
tive approach of choice. To address this, this review will provide a
comprehensive analysis of trials exploring the use of mesh in the
context of all operative approaches. The previous Cochrane review
considering mesh versus non-mesh repairs specified only open re-
pair as an inclusion criterion, and did not include the increasingly
favoured laparoscopic approach.
O B J E C T I V E S
To evaluate the outcomes of inguinal and femoral hernia repair
techniques in adults, specifically comparing closure with mesh
versus without mesh.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All individual parallel and cluster randomised controlled trials
(RCTs) investigating mesh techniques for open or laparoscopic
repair of inguinal or femoral hernias are eligible for inclusion.
Types of participants
All persons with a clinically diagnosed inguinal or femoral hernia,
or both, where surgical management is indicated.
Types of interventions
Any of the following mainstream techniques for surgical repair of
an inguinal or femoral hernia are accepted:
• Concerning inguinal hernias:
◦ Mesh repairs:
⋄ Open; including Lichtenstein approach
⋄ Laparoscopic; including transabdominal
preperitoneal (TAPP) and totally extraperitoneal (TEP)
approaches
⋄ Any type of commercially marketed non-
absorbable mesh or absorbable biomesh may be used; including
’plug-and-patch’ kits (that is, absorbable plugs/tacks with (non-
)absorbable patch/mesh)
◦ Suture repairs:
⋄ Tension; including Bassini, McVay and
Shouldice approaches
⋄ Tension-free; including Desarda and Guarnieri
approaches
⋄ Any type of commercially marketed non-
absorbable or absorbable sutures may be used
• Concerning femoral hernias:
◦ Mesh repairs:
⋄ Open mesh/mesh plug repair
⋄ Laparoscopic; including TAPP or TEP
approaches
⋄ Any type of commercially marketed non-
absorbable mesh or absorbable biomesh may be used; including
’plug-and-patch’ kits (that is, absorbable plugs/tacks with (non-
)absorbable patch/mesh)
◦ Suture repairs:
⋄ Open McVay suture repair; including
Lockwood’s infra-inguinal, Lotheissen’s trans-inguinal and
McEvedy’s high approaches
⋄ Any type of commercially marketed non-
absorbable or absorbable sutures may be used
Types of outcome measures
Primary outcomes
1. Recurrence of the same hernia (i.e. excludes formation of a
hernia at a new site not previously repaired or reinforced) due to:
i) Failure of operation (with recurrence within 3 months
of surgery, unless otherwise specified)
ii) Weakening of the abdominal wall (with recurrence
occurring after 12 months of surgery, unless otherwise specified)
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2. Surgical complications, including but not limited to:
i) Acute (within 30 days of surgery) major
complications: neurovascular or visceral injury, wound
dehiscence and deep wound (and mesh) infections
ii) Acute (within 30 days of surgery) minor
complications: haematoma or seroma formation, and superficial
wound infections
iii) Chronic (present at one year postoperatively and for at
least three months in duration) complications: chronic pain,
paraesthesia or numbness (measurable using standardised pain
and numbness scores, for example, Visual Analogue Scales,
which can be reassessed at 3, 6, 9 and 12 months).
Secondary outcomes
1. Duration of surgical operation (measurable in minutes)
2. Duration of postoperative hospital stay (measurable in days)
3. Time required to return to full activities of daily living
including work and exercise (measurable in days)
4. Number of operations where ’opposite’ method had to be
initiated (that is, conversion from laparoscopic to open approach)
5. Mortality (that is, number of associated deaths within 30
days of the operation during the study trial period)
6. Cost of surgery and hospital admission
Search methods for identification of studies
Electronic searches
Wewill search the Cochrane Colorectal Cancer Group Specialized
Register, Cochrane Central Register of Controlled Trials (CEN-
TRAL) latest issue (Appendix 1), MEDLINE (1950 to current
date) (Appendix 2), EMBASE (1974 to current date) (Appendix
3) and Web of Science (1985 to current date) (Appendix 4).
We will impose no publication or language restrictions.
Searching other resources
We will search relevant clinical trials registers such as the World
Health Organization (WHO) International Clinical Trials Reg-
istry Platform (ICTRP) (http://www.who.int/ictrp/en/) andClin-
icalTrials.gov (http://clinicaltrials.gov/) for completed and ongo-
ing trials.Wewill also search reference lists of included trials and re-
view articles, search books related to surgical hernia repairs, search
abstracts from general surgical conferences concerning hernias and
mesh repair, and send written enquiries to the authors of major
relevant studies and experts in the field. We will also contact phar-
maceutical companies to obtain access to any unpublished trial
data, should there be any.
Data collection and analysis
Selection of studies
Three review authors (KL, ET, ST) will assess titles and abstracts
retrieved from the search to determine their relevance concern-
ing the objectives of this review. We will manage disagreements
through discussion, a deciding arbiter (MD) or both. We will en-
ter all search results into Review Manager 5.3 (RevMan 2014).
Data extraction and management
Two review authors (KL, ET) will design a data extraction sheet
for study reports, which will be pilot tested using sample studies
and revised by the other authors (MD, MVD). Onto this report,
two authors (KL, ST) will independently extract and record key
features of each study including details of the:
• Authors
• Date and place of publication
• Study design
• Inclusion and exclusion criteria
• Setting
• Summary of study participant characteristics
• Summary of intervention and control conditions
• Number of participants in each arm (including dropouts)
• Adverse events
• Outcome measurement and assessment time points
• Risk of bias (as per the domains specified in Assessment of
risk of bias in included studies)
• Any relevant additional comments reported by the study
authors
We will manage disagreements through discussion, a deciding ar-
biter (MVD) or both. We will enter and present the data for
each included study into a table in Review Manager 5.3 (RevMan
2014).
Assessment of risk of bias in included studies
Two review authors (KL, ST) will independently analyse each
study in conjunction with The Cochrane Collaboration’s tool for
assessing ’Risk of bias’ (Higgins 2011). This approach uses a do-
main-based evaluation that aims to address main potential areas of
bias in studies, where a grade (that is, either low, high or unclear)
is assigned for each of the following domains:
• Random sequence generation (low risk if true random
sequence generation was described)
• Allocation concealment (low risk if sealed, opaque,
numbered envelopes or central allocation after registration)
• Blinding of participants and assessors (low risk if both the
participant and the assessor were blinded to either intervention
or treatment arms)
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• Incomplete or selective outcome data reporting (low risk if
> 80% of those randomly assigned were assessed)
• Any other potential sources of bias (such as, study stopped
early because of a data-dependent process, notable baseline
imbalance, study funding from a profit-based organisation,
surgeon competence or experience).
A high risk of bias indicates that the study design has not met
the criteria for a low risk classification as noted above for each of
the respective domains. Similarly, an unclear risk of bias denotes
that the study has not declared sufficient information regarding
their study design to make a judgement. We will manage any
disagreements through discussion, a deciding arbiter (MVD) or
both.Wewill present our assessment of risk of bias for the included
studies in the ’Risk of bias’ summary tables and graphs as generated
through input into Review Manager 5.3 (RevMan 2014).
Measures of treatment effect
1. We will present dichotomous (binary) data as a measure of
risk and relative risk by using an odds ratio (OR) with 95%
confidence intervals (CIs). Where possible, we will calculate the
absolute risk reduction (ARR) and number needed to treat to
benefit (NNTB) or number needed to treat to harm (NNTH)
for comparison against other treatments or non-treatment.
2. We will present continuous data as a mean difference (MD)
if the same scale is used. Alternatively, a standardised mean
difference (SMD) will be calculated (that is, an average of the
combined standard deviations) in the event that each study uses
a different scale. In this case, we will also assess the impact of
using the highest verses the lowest of the available standard
deviations (SD) on the overall estimate of effect. If SDs are not
reported we will estimate the SD based on similar studies and use
this in the meta-analysis (Higgins 2011).
3. We will present data reported as rates as a rate ratio. We will
use rates to express outcomes over time. This may be expressed as
a rate ratio, which may demonstrate outcomes more clearly than
a risk ratio as it accounts for the likelihood that some
participants may experience multiple events (Higgins 2011).
Unit of analysis issues
We envisage that the unit of analysis in our review will be the
participant. Nonetheless:
1. if the unit of analysis is not the same as the unit of
randomisation, such as in cluster-randomised trials, we plan to
adjust for clustering by using the guidance given in the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011);
2. if there are multiple measurements for the same participant
(e.g. multiple hernias in the same person), we plan to analyse the
data as in a cluster-randomised trial.
Dealing with missing data
We intend to contact the trial authors of the original studies when
further data or information is required. We will perform analyses
based on intention-to-treat (ITT) principles, whereby the missing
data for randomised participants will be assumed to be treatment
failures in this review. This approach of ITT analysis (that is,
assuming drop-outs as failures) may underestimate the effect of
the intervention, therefore we may perform both ITT and on-
treatment (that is, non-ITT) analyses to explore the impact of
missing data on the overall outcome (Higgins 2011). Furthermore,
for continuous datawewill assess the impact ofmissing data on the
overall estimate of effect by imputing missing data in the following
ways: best case scenario where the missing data are considered 2
SD greater in the intervention arm than in the control arm and
worst case scenario where the missing data are considered 2 SD
less than in the control arm.
Assessment of heterogeneity
Wewill assess the included studies for heterogeneity through three
successive steps to determine if they should be pooled with the rest
of the included studies or considered separately:
1. Two review authors will independently analyse the included
studies for their ’face-value’ similarities; that is, for the extent of
clinical of diversity (participants, interventions and outcomes),
and for methodological diversity (study design and risk of bias).
2. We then intend to assess the included studies for statistical
heterogeneity using the Chi2 test with a P value of less than 0.10
being statistically significant.
3. We then intend to calculate the I2 statistic as instructed in
the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011); where 0% to 40% is likely to indicate minimal
heterogeneity, 30% to 60% may represent moderate
heterogeneity, 60% to 90% may represent substantial
heterogeneity, and 90% to 100% may represent considerably
significant heterogeneity. The importance of the observed value
of I2 does depend on the magnitude and direction of the
treatment effects, and strength of evidence for heterogeneity
(that is, the P value from the Chi2 test or the confidence interval
for I2).
Assessment of reporting biases
If a sufficient number of studies have been pooled (that is, greater
than 10, we plan to use a funnel plot to inspect visually the risk
of publication bias, whereby more pronounced asymmetry of the
funnel plot may be indicative of a substantial overestimation of
the intervention effect (Higgins 2011).
Data synthesis
We will synthesise the data using one of these two methods:
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1. We will use the fixed-effect model in the absence of
statistical heterogeneity according to the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011), where the
analysis will produce an estimate of the true effect.
2. We will use the random-effects model in the event of
statistical heterogeneity for pooling the study data using the
Mantel-Haenszel method according to the Cochrane Handbook
for Systematic Review of Interventions (Higgins 2011), where the
analysis produces an average effect. In the event that there is an
insufficient number of studies to produce an average effect in a
random-effects model, a fixed-effect model will be used.
3. Where cluster RCTs are included, we will use the generic
inverse variance method (Higgins 2011).
If studies are clinically heterogeneous, we will not pool them in
meta-analysis.
Subgroup analysis and investigation of heterogeneity
If sufficient data are available, we intend to explore further the
treatment effect in specific subgroups, including:
• inguinal versus femoral hernia;
• direct versus indirect inguinal hernia;
• male versus female participants;
• elective versus emergency surgery;
• different types of mesh; for example, biological versus
composite synthetics.
Sensitivity analysis
If sufficient data are available, we intend to perform sensitivity
analyses:
1. In order to determine the impact of risk of bias on the
overall effect estimate, we will add high risk of bias studies to low
risk of bias studies and compare the results.
2. In order to determine the impact of heterogeneity on the
overall estimate of effect, we will remove studies that contribute
to heterogeneity from the analyses and compare the results.
We intend to use two different methods of pooling to test sensi-
tivity by pooling all studies together and then removing studies
from the meta-analysis one by one, and noting if there has been
any significant change in the overall results; simultaneously, we
will also compare the use of a fixed-effect versus random-effects
model for the pooling analysis as we exclude each study one by
one.
A C K N OW L E D G E M E N T S
This review has been published previously inThe Cochrane Library
(Scott 2001). We would like to acknowledge the work of the pre-
vious authors: Scott N, Go PM, Graham P, McCormack K, Ross
S, Grant A.
R E F E R E N C E S
Additional references
Amid 2005
Amid PK. Groin hernia repair: open techniques. World
Journal of Surgery 2005;28(8):1046–51.
Bittner 2011
Bittner R, Arregui ME, Bisgaard T, Dudai M, Ferzli
GS, Fitzgibbons RJ, et al. Guidelines for laparoscopic
(TAPP) and endoscopic (TEP) treatment of inguinal hernia
[International Endohernia Society (IEHS)]. Journal of
Endoscopic Surgery 2011;25(9):2773–843.
Brooks 2014a
Brooks DC, Obeid A, Hawn M. Classification, clinical
features and diagnosis of inguinal and femoral hernias in
adults. Up To Date 2014.
Brooks 2014b
Brooks DC. Overview of treatment for inguinal and femoral
hernia in adults. Up To Date 2014.
Brooks 2014c
Brooks DC. Overview of complications of inguinal and
femoral hernia repair. Up To Date 2014.
Brown 2010
Brown CN, Finch JG. Which mesh for hernia repair?.
Annals of the Royal College of Surgeons, England 2010;92(4):
272–8.
Cannon 1981
Cannon DJ, Read RC.Metastatic emphysema: a mechanism
for acquiring inguinal herniation. Annals of Surgery 1981;
194(3):270–8.
Dahlstrand 2009
Dahlstrand U, Wollert S, Nordin P, Sandblom G,
Gunnarsson U. Emergency femoral hernia repair: a study
based on a national register. Annals of Surgery 2009;249(4):
672.
Doctor 2006
Doctor HG. Evaluation of various prosthetic materials and
newer meshes for hernia repairs. Journal of Minimal Access
Surgery 2006;2(3):110–6.
EU Hernia Trialists 2002
The EU Hernia Trialists Collaboration. Repair of groin
hernia with synthetic mesh: meta-analysis of RCT. Annals
of Surgery 2002;235:322–32.
7Mesh versus non-mesh for inguinal and femoral hernia repair (Protocol)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ferzli 1998
Ferzli G, Sayad P, Huie F, Hallak A, Usal H. Endoscopic
extraperitoneal herniorrhaphy. A 5-year experience. Journal
of Endoscopic Surgery 1998;12(11):1311.
Fitzgibbons 2006
Fitzgibbons RJ Jr, Giobbie-Hurder A, Gibbs JO, Dunlop
DD, Reda DJ, et al. Watchful waiting vs repair of inguinal
hernia in minimally symptomatic men: a randomized
clinical trial. JAMA 2006;295(3):285.
Gallegos 1991
Gallegos NC, Dawson J, Jarvis M, Hobsley M. Risk of
strangulation in groin hernias. British Journal of Surgery
1991;78(10):1171.
Higgins 2011
Higgins JPT, Green S (editors). Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0
[updated March 2011]. The Cochrane Collaboration,
2011. Available from www.cochrane-handbook.org.
Jenkins 2008
Jenkins JT, O’Dwyer PJ. Inguinal hernias. BMJ 2008;336:
269–72.
Klinge 2002
Klinge U, Klosterhalfen B, Birkenhauer V, Junge K, Conze
J, Schumpelick V. Impact of polymer pore size on the
interface scar formation in a rat model. Journal of the
Surgical Resident 2002;103:208–14.
Klinge 2008
Klinge U. Mesh for hernia repair. British Journal of Surgery
2008;95:539–40.
Koch 2005
Koch A, Edwards A, Haapaniemi S, Nordin P, Kald A.
Prospective evaluation of 6895 groin hernia repairs in
women. British Journal of Surgery 2005;92(12):1553.
Liem 1997
Liem MS, van der Graaf Y, Zwart RC, Geurts I, van
Vroonhoven TJ. Risk factors for inguinal hernia in women:
a case-control study. The Coala Trial Group. American
Journal of Epidemiology 1997;146(9):721–6.
McCormack 2003
McCormack K, Scott N, Go PM, Ross SJ, Grant A,
Collaboration the EU Hernia Trialists. Laparoscopic
techniques versus open techniques for inguinal hernia
repair. Cochrane Database of Systematic Reviews 2003, Issue
1. [DOI: 10.1002/14651858.CD001785]
McKernan 1993
McKernan JB, Laws H. Laparoscopic repair of inguinal
hernias using a totally extraperitoneal prosthetic approach.
Journal of Endoscopic Surgery 1993;7(1):26.
Nixon 2009
Nixon SJ, Jawaid H. Recurrence after inguinal hernia
repair at ten years by open darn, open mesh and TEP - no
advantage with mesh. The Surgeon 2009;7:71–4.
O’Dwyer 2005
O’Dwyer, Kingsworth AN,Molloy RG, Small PK, Lammers
B, et al. Randomized clinical trial assessing impact of a
lightweight or heavyweight mesh on chronic pain after
inguinal hernia repair. British Journal of Surgery 2005;92:
166–70.
O’Dwyer 2006
O’Dwyer PJ, Norrie J, Alani A, Walker A, Duffy F, et al.
Observation or operation for patients with an asymptomatic
inguinal hernia: a randomized clinical trial. Annals of
Surgery 2006;244(2):167.
Read 1999
Read RC. Francis C. Usher, herniologist of the twentieth
century. Hernia 1999;3(3):167–71.
RevMan 2014
The Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager (RevMan). 5.3. Copenhagen: The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014.
Rosemar 2008
Rosemar A, Angeras U, Rosengren A. Body mass index and
groin hernia: a 34-year follow-up study in Swedish men.
Annals of Surgery 2008;247(6):1064.
Rosemar 2010
Rosemar A, Angeras U, Rosengren A, Nordin P. Effect of
body mass index on groin hernia surgery. Annals of Surgery
2010;252(2):397–401.
Ruhl 2007
Ruhl CE, Everhart JE. Risk factors for inguinal hernia
among adults in the US population. American Journal of
Epidemiology 2007;165(10):1154–61.
Rutkow 1993
Rutkow IM, Robbins AW. Demographic, classificatory, and
socioeconomic aspects of hernia repair in the United States.
Surgical Clinics of North America 1993;73(3):413.
Sorenson 2002
Sorenson LT, Friis E, Jorgensen T, Vennits B, Andersen BR,
Rasmussen GI, et al. Smoking is a risk factor for recurrence
of groin hernia. World Journal of Surgery 2002;26(4):
397–400.
Vader 1997
Vader VL, Vogt DM, Zucker KA, Thilstead JP, Curet MJ.
Adhesion formation in laparoscopic inguinal hernia repair.
Journal of Endoscopic Surgery 1997;11(8):825.
Wake 2005
Wake BL, McCormack K, Fraser C, Vale L, Perez J,
Grant A. Transabdominal pre-peritoneal (TAPP) vs totally
extraperitoneal (TEP) laparoscopic techniques for inguinal
hernia repair. Cochrane Database of Systematic Reviews 2005,
Issue 1. [DOI: 10.1002/14651858.CD004703.pub2]
Whalen 2011
Whalen HR, Kidd GA, O’Dwyer PJ. Femoral hernias. BMJ
2011;343:d7668.
Yang 2011
Yang J, Papandria D, Rhee D, Perry H, Abdullah F. Low-
cost mesh for inguinal hernia repair in resource-limited
settings. Hernia 2011;15:485–9.
8Mesh versus non-mesh for inguinal and femoral hernia repair (Protocol)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
References to other published versions of this review
Scott 2001
Scott N, Go PM, Graham P, McCormack K, Ross SJ, Grant
AM. Open mesh versus non-mesh for groin hernia repair.
Cochrane Database of Systematic Reviews 2001, Issue 3.
[DOI: 10.1002/14651858.CD002197]
∗ Indicates the major publication for the study
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Hernia, Inguinal] explode all trees
#2 MeSH descriptor: [Hernia, Femoral] explode all trees
#3 ((Inguina* or femoral or groin*) and herni*):ti,ab,kw
#4 (#1 or #2 or #3)
#5 MeSH descriptor: [Laparoscopy] explode all trees
#6 MeSH descriptor: [Herniorrhaphy] explode all trees
#7 MeSH descriptor: [Sutures] explode all trees
#8 ((laparascop* or open or hernia*) and (repair or surg* or intervent* or operat* or approach* or technique*)):ti,ab,kw
#9 (herniorrhaph* or hernioplast* or sutur* or tension* or Lichtenstein* or transabdominal preperitoneal or TAPP or totally extraperi-
toneal or TEP or Bassini* or McVay* or Shouldice* or Desarda* or Guarnieri* or Lockwood* or Lotheissen* or McEvedy*):ti,ab,kw
#10 (#5 or #6 or #7 or #8 or #9)
#11 MeSH descriptor: [Surgical Mesh] explode all trees
#12 (mesh* or plug*):ti,ab,kw
#13 (#11 or #12)
#14 (#4 and #10 and #13)
Appendix 2. MEDLINE (Ovid) search strategy
1. exp Hernia, Inguinal/
2. exp Hernia, Femoral/
3. ((Inguina* or femoral or groin*) and herni*).mp.
4. 1 or 2 or 3
5. exp Laparoscopy/
6. exp Herniorrhaphy/
7. exp Sutures/
8. ((laparascop* or open or hernia*) and (repair or surg* or intervent* or operat* or approach* or technique*)).mp.
9. (herniorrhaph* or hernioplast* or sutur* or tension* or Lichtenstein* or transabdominal preperitoneal or TAPP or totally extraperi-
toneal or TEP or Bassini* or McVay* or Shouldice* or Desarda* or Guarnieri* or Lockwood* or Lotheissen* or McEvedy*).mp.
10. 5 or 6 or 7 or 8 or 9
11. exp Surgical Mesh/
12. (mesh* or plug*).mp.
13. 11 or 12
14. 4 and 10 and 13
15. randomized controlled trial.pt.
16. controlled clinical trial.pt.
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17. randomized.ab.
18. placebo.ab.
19. clinical trial.sh.
20. randomly.ab.
21. trial.ti.
22. 15 or 16 or 17 or 18 or 19 or 20 or 21
23. humans.sh.
24. 22 and 23
25. 14 and 24
Appendix 3. EMBASE (Ovid) search strategy
1. exp inguinal hernia/
2. exp femoral hernia/
3. ((Inguina* or femoral or groin*) and herni*).mp.
4. 1 or 2 or 3
5. exp laparoscopy/
6. exp herniorrhaphy/
7. exp suture/
8. ((laparascop* or open or hernia*) and (repair or surg* or intervent* or operat* or approach* or technique*)).mp.
9. (herniorrhaph* or hernioplast* or sutur* or tension* or Lichtenstein* or transabdominal preperitoneal or TAPP or totally extraperi-
toneal or TEP or Bassini* or McVay* or Shouldice* or Desarda* or Guarnieri* or Lockwood* or Lotheissen* or McEvedy*).mp.
10. 5 or 6 or 7 or 8 or 9
11. exp surgical mesh/
12. (mesh* or plug*).mp
13. 11 or 12
14. 4 and 10 and 13
15. CROSSOVER PROCEDURE.sh.
16. DOUBLE-BLIND PROCEDURE.sh.
17. SINGLE-BLIND PROCEDURE.sh.
18. (crossover* or cross over*).ti,ab.
19. placebo*.ti,ab.
20. (doubl* adj blind*).ti,ab.
21. allocat*.ti,ab.
22. trial.ti.
23. RANDOMIZED CONTROLLED TRIAL.sh.
24. random*.ti,ab.
25. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
26. 14 and 25
Appendix 4. Science Citation Index-Expanded/Conference Proceedings Citation Index-Science
#1 TI=(((Inguina* or femoral or groin*) and herni*))
#2 TOPIC: (((laparascop* or open or hernia*) and (repair or surg* or intervent* or operat* or approach* or technique*)))
#3 TOPIC: ((herniorrhaph* or hernioplast* or sutur* or tension* or Lichtenstein* or transabdominal preperitoneal or TAPP or totally
extraperitoneal or TEP or Bassini* or McVay* or Shouldice* or Desarda* or Guarnieri* or Lockwood* or Lotheissen* or McEvedy*))
#4 (#3 OR #2)
#5 TI=((mesh* or plug*))
#6 (#5 AND #4 AND #1)
#7 TOPIC: (((controlled trial or controlled clinical trial or placebo or clinical trial or random* or trial or cct or rct)))
#8 (#7 AND #6)
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